- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PI3K inhibitor BYL719
Total 64518 results
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaRecruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
Columbia UniversityCompleted
-
SecuraBioTerminatedLymphoma | Lymphoma, Non-Hodgkin | Follicular Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
PIQUR Therapeutics AGCharite University, Berlin, Germany; University Hospital, Basel, Switzerland; University Hospital Freiburg and other collaboratorsCompletedLymphoma | Non-Hodgkin LymphomaGermany
-
PIQUR Therapeutics AGM.D. Anderson Cancer Center; Mayo Clinic; University College London Hospitals; Hospital... and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompleted
-
PIQUR Therapeutics AGRoyal Marsden NHS Foundation Trust; University College London Hospitals; Weill... and other collaboratorsCompletedLymphoma, MalignantUnited States, United Kingdom, Serbia, Bosnia and Herzegovina, France, Israel
-
Kazia Therapeutics LimitedQuotient SciencesCompleted
-
Novartis PharmaceuticalsAvailablePIK3CA-Related Overgrowth Spectrum (PROS)
-
Lawson Health Research InstituteActive, not recruitingHead and Neck Squamous Cell CancerCanada
-
Northwestern UniversityNational Cancer Institute (NCI); NovartisCompletedBYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
Yonsei UniversityUnknownRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
SecuraBioCompletedAsthmaGermany, United Kingdom
-
University of ArizonaNational Cancer Institute (NCI)TerminatedHPV Positive Oropharyngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | CDKN2A-p16 Positive | Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7 | Stage II Oropharyngeal Squamous Cell Carcinoma...United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Recurrent Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingPIK3CA-related Overgrowth Spectrum (PROS)Spain, France, Ireland, United States
-
New Mexico Cancer Care AllianceNo longer available
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Anne ChangNovartis PharmaceuticalsTerminatedCarcinoma, Basal Cell | Skin Neoplasms | Basal Cell Nevus Syndrome | Recurrent Skin CancerUnited States
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Rhizen Pharmaceuticals SACompletedLymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralUnited States
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
NRG OncologyNational Cancer Institute (NCI)CompletedEndometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Metastatic Endometrioid AdenocarcinomaUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Novartis PharmaceuticalsRecruitingLymphatic MalformationsSpain, France, Germany, Australia, United States
-
Rhizen Pharmaceuticals SACompletedLymphoma, B-Cell | T-Cell LymphomaFrance, Italy
-
SecuraBioCompletedA Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, Germany, United Kingdom, Australia
-
SecuraBioCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, United Kingdom, Australia, Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eli Lilly and Company; Genentech, Inc.; Kazia... and other collaboratorsRecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Brain | NTRK Family Gene Mutation | CDK Gene Mutation | PI3K Gene Mutation | ROS1 Gene Mutation | KRAS G12C MutationUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Rhizen Pharmaceuticals SACompleted
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterWithdrawnLocally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Bone
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Genentech, Inc.Completed
-
Pamela MunsterNovartisWithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Solid Tumors, Adult | HPV-Related Squamous Cell Carcinoma | Human Papillomavirus-Related Carcinoma | PIK3CA Mutation-Related Tumors | PIK3CA Mutation | Human Papillomavirus-Related Squamous Cell CarcinomaUnited States
-
Karus Therapeutics LimitedCompletedLymphoma, B CellUnited States
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
EMD SeronoSanofiCompletedMelanoma | Breast Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Italy, Spain
-
M.D. Anderson Cancer CenterTerminated
-
Centre Hospitalier Universitaire DijonNovartis PharmaceuticalsRecruitingMegalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)France
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada